These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11673407)

  • 1. Triplex forming oligonucleotides: sequence-specific tools for gene targeting.
    Knauert MP; Glazer PM
    Hum Mol Genet; 2001 Oct; 10(20):2243-51. PubMed ID: 11673407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene targeting via triple-helix formation.
    Casey BP; Glazer PM
    Prog Nucleic Acid Res Mol Biol; 2001; 67():163-92. PubMed ID: 11525382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triplex-induced recombination and repair in the pyrimidine motif.
    Kalish JM; Seidman MM; Weeks DL; Glazer PM
    Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene modification using triplex-forming oligonucleotides.
    Kuan JY; Glazer PM
    Methods Mol Biol; 2004; 262():173-94. PubMed ID: 14769962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted genome modification via triple helix formation.
    Kalish JM; Glazer PM
    Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted genome modification via triple helix formation.
    Ricciardi AS; McNeer NA; Anandalingam KK; Saltzman WM; Glazer PM
    Methods Mol Biol; 2014; 1176():89-106. PubMed ID: 25030921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair of DNA lesions associated with triplex-forming oligonucleotides.
    Chin JY; Glazer PM
    Mol Carcinog; 2009 Apr; 48(4):389-99. PubMed ID: 19072762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triplex-forming oligonucleotides as potential tools for modulation of gene expression.
    Rogers FA; Lloyd JA; Glazer PM
    Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):319-26. PubMed ID: 16101484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplex-mediated gene modification.
    Schleifman EB; Chin JY; Glazer PM
    Methods Mol Biol; 2008; 435():175-90. PubMed ID: 18370076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplex-mediated genome targeting and editing.
    Reza F; Glazer PM
    Methods Mol Biol; 2014; 1114():115-42. PubMed ID: 24557900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
    Rogers FA; Lloyd JA; Tiwari MK
    Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides.
    Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM
    Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed gene modification via triple helix formation.
    Gorman L; Glazer PM
    Curr Mol Med; 2001 Jul; 1(3):391-9. PubMed ID: 11899085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
    Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
    Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence.
    Simon P; Cannata F; Concordet JP; Giovannangeli C
    Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides.
    Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific gene modification by PNAs conjugated to psoralen.
    Kim KH; Nielsen PE; Glazer PM
    Biochemistry; 2006 Jan; 45(1):314-23. PubMed ID: 16388608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
    Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
    Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling DNA Triplex Assembly: Mass Spectrometric Investigation of Modified Triplex Forming Oligonucleotides for Enhanced Gene Targeting.
    Chandrasegaran S; Klose JW; Pukala TL
    J Am Soc Mass Spectrom; 2024 Sep; 35(9):2056-2063. PubMed ID: 39088835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico search of DNA drugs targeting oncogenes.
    Papadakis G; Gizeli E
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1826-30. PubMed ID: 23221090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.